(Q44979528)

7 December 2017

Effects of ospemifene, a novel SERM, on biochemical markers of bone turnover in healthy postmenopausal women (English)

1 reference

7 December 2017

Komi J

1

1 reference

7 December 2017

Heikkinen J

2

1 reference

7 December 2017

Rutanen EM

3

1 reference

7 December 2017

Halonen K

4

1 reference

7 December 2017

Lammintausta R

5

1 reference

7 December 2017

Ylikorkala O

6

1 reference

7 December 2017

1 March 2004

1 reference

Gynecological Endocrinology

7 December 2017

1 reference

7 December 2017

18

1 reference

7 December 2017

3

1 reference

7 December 2017

152-158

1 reference

Perspective. How many women have osteoporosis?

7 December 2017

1 reference

https://api.crossref.org/works/10.1080%2F09513590410001672197

Hormone therapy to prevent disease and prolong life in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590410001672197

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590410001672197

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590410001672197

Effects of ospemifene (FC-1271a) on uterine endometrium, vaginal maturation index, and hormonal status in healthy postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590410001672197

The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590410001672197

Effects of ospemifene, a novel SERM, on vascular markers and function in healthy, postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590410001672197

Cardiovascular effects of raloxifene hydrochloride.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590410001672197

Comparison of effects of tamoxifen and toremifene on bone biochemistry and bone mineral density in postmenopausal breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590410001672197

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590410001672197

Treatment of established postmenopausal osteoporosis with raloxifene: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590410001672197

10.1080/09513590410001672197

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference